Remedium Lifecare Ltd

Remedium Lifecare Ltd’s share price declined to a fresh 52-week low of ₹0.35 on 24 March 2026, marking a significant downturn for the micro-cap company within the Trading & Distributors sector. The stock has experienced sustained pressure, reflecting a series of financial setbacks and market headwinds.

For the seventh consecutive session, Remedium Lifecare Ltd has closed lower, culminating in a fresh 52-week low of Rs 0.36 on 23 Mar 2026. This marks a steep 23.4% decline over the past week, underscoring persistent selling pressure amid a challenging market backdrop.

For the seventh consecutive session, Remedium Lifecare Ltd has closed lower, culminating in a fresh 52-week low of Rs 0.36 on 23 Mar 2026. This marks a steep 23.4% decline over the past week, underscoring persistent selling pressure amid a broader market downturn.

Remedium Lifecare Ltd’s stock price declined sharply to a new 52-week and all-time low of Rs.0.37 on 20 Mar 2026, marking a significant downturn for the micro-cap company in the Trading & Distributors sector. The stock has underperformed its sector and broader market indices amid persistent negative financial results and subdued operational metrics.

Remedium Lifecare Ltd, a micro-cap player in the Trading & Distributors sector, has touched a fresh 52-week and all-time low of Rs.0.38 today, marking a significant decline in its stock price amid continued underperformance and challenging financial metrics.

Remedium Lifecare Ltd has reached a new 52-week and all-time low of Rs.0.39, marking a significant decline in its stock price amid ongoing negative financial performance and sector underperformance.

Remedium Lifecare Ltd has touched a new 52-week and all-time low of Rs.0.4 today, marking a significant decline in its stock price amid ongoing financial difficulties and subdued market sentiment. This latest low comes after a prolonged period of underperformance relative to its sector and benchmark indices.

Remedium Lifecare Ltd’s stock price declined sharply to a new 52-week and all-time low of Rs.0.41 today, marking a significant downturn amid ongoing financial difficulties and subdued market sentiment within the Trading & Distributors sector.

Remedium Lifecare Ltd’s shares declined sharply to a new 52-week and all-time low of Rs.0.45 on 5 March 2026, marking a significant downturn for the stock within the Trading & Distributors sector. The stock has underperformed its sector and broader market indices amid a series of challenging financial results and valuation concerns.

Remedium Lifecare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 16 Nov 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed here represent the company’s current position as of 05 March 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance.

Remedium Lifecare Ltd’s shares declined sharply to a new 52-week low of Rs.0.5, marking a significant milestone in the stock’s ongoing downward trajectory. This fresh low comes amid a series of disappointing financial results and subdued market performance, reflecting persistent challenges faced by the company within the Trading & Distributors sector.

Remedium Lifecare Ltd’s stock price touched a new 52-week and all-time low of Rs.0.5 today, marking a significant decline amid ongoing financial pressures and subdued sector performance. This latest low reflects a year-long downward trajectory with the stock underperforming key benchmarks and trading well below all major moving averages.

Remedium Lifecare Ltd’s stock price touched a new 52-week and all-time low of Rs.0.55 today, marking a significant decline amid sustained negative performance. The stock has underperformed its sector and broader market indices, reflecting ongoing financial pressures and subdued business metrics.

Remedium Lifecare Ltd has touched a new 52-week and all-time low of Rs.0.68 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing financial pressures and subdued business performance.

Remedium Lifecare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 16 November 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below are based on the company’s current position as of 21 February 2026, providing investors with the latest insights into its performance and prospects.

Remedium Lifecare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 16 November 2024. However, the analysis and financial metrics presented here reflect the company’s current position as of 10 February 2026, providing investors with an up-to-date view of its performance and outlook.

Remedium Lifecare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 16 Nov 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below are based on the company’s current position as of 30 January 2026, providing investors with the latest perspective on its performance and prospects.